Transgender patients may have increased risk of cardiovascular diseases

09 Nov 2020


According to a study presented at the American Heart Association Scientific Sessions 2020, transgender patients undergoing gender-affirming hormone therapy may have an increased risk of cardiovascular diseases.

Cardiology Advisor


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story